Morgan Stanley analyst Steve Beuchaw resumed coverage of Thermo Fisher with an Overweight rating and $220 price target, contending that consensus EPS estimates for 2018 and 2019 are too low and that the company's longer-term opportunity in the highly fragmented CDMO market is underappreciated.
Deutsche Bank raised the firm's price target on Thermo Fisher to $610 from $600 and keeps a Buy rating on the shares post the Q1 report. The analyst says a solid operational performance drove a strong start to 2024.
Barclays analyst Luke Sergott raised the firm's price target on Thermo Fisher to $615 from $590 and keeps an Equal Weight rating on the shares. The company reported a beat across the board, says the analyst, who sees the business stabilizing.
Check out this morning's top movers from around Wall Street, compiled by The Fly. UP AFTER EARNINGS... To see the rest of the story go to thefly.com. See Story Here